Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,206,844
-
Share change
-
-22,383
-
Total reported value
-
$57,132,948
-
Price per share
-
$47.37
-
Number of holders
-
70
-
Value change
-
-$1,297,503
-
Number of buys
-
16
-
Number of sells
-
32
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q3 2019
As of 30 Sep 2019 INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) had 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,206,844 shares of stock of the company.
Largest 10 holders included CLS Investments, LLC, MORGAN STANLEY, ROYAL BANK OF CANADA, UBS Group AG, LADENBURG THALMANN FINANCIAL SERVICES INC., WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and PFG Advisors.
This table shows 71 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.